Search Results - "Friedland, Julie C"

  • Showing 1 - 20 results of 20
Refine Results
  1. 1
  2. 2

    Potent activity of the Hsp90 inhibitor ganetespib in prostate cancer cells irrespective of androgen receptor status or variant receptor expression by HE, SUQIN, ZHANG, CHAOHUA, SHAFI, AYESHA A, SEQUEIRA, MANUEL, ACQUAVIVA, JAIME, FRIEDLAND, JULIE C, SANG, JIM, SMITH, DONALD L, WEIGEL, NANCY L, WADA, YUMIKO, PROIA, DAVID A

    Published in International journal of oncology (01-01-2013)
    “…Androgen ablation therapy represents the first line of therapeutic intervention in men with advanced or recurrent prostate tumors. However, the incomplete…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Mechanically Activated Integrin Switch Controls α₅β₁ Function by Friedland, Julie C, Lee, Mark H, Boettiger, David

    “…The cytoskeleton, integrin-mediated adhesion, and substrate stiffness control a common set of cell functions required for development and homeostasis that are…”
    Get full text
    Journal Article
  6. 6

    Targeting KRAS-mutant non-small cell lung cancer with the Hsp90 inhibitor ganetespib by Acquaviva, Jaime, Smith, Donald L, Sang, Jim, Friedland, Julie C, He, Suqin, Sequeira, Manuel, Zhang, Chaohua, Wada, Yumiko, Proia, David A

    Published in Molecular cancer therapeutics (01-12-2012)
    “…Mutant KRAS is a feature of more than 25% of non-small cell lung cancers (NSCLC) and represents one of the most prevalent oncogenic drivers in this disease…”
    Get full text
    Journal Article
  7. 7

    Case report: response to the ERK1/2 inhibitor ulixertinib in BRAF D594G cutaneous melanoma by Wolfe, Zachary, Friedland, Julie C., Ginn, Sarah, Blackham, Aaron, Demberger, Lauren, Horton, Morgan, McIntosh, Alyson, Sheikh, Hina, Box, Jessica, Knoerzer, Deborah, Federowicz, Bryan, Stuhlmiller, Timothy J., Shapiro, Mark, Nair, Suresh

    Published in Melanoma research (01-08-2022)
    “…Melanoma is characterized by oncogenic mutations in pathways regulating cell growth, proliferation, and metabolism. Greater than 80% of primary melanoma cases…”
    Get full text
    Journal Article
  8. 8

    Targeted inhibition of Hsp90 by ganetespib is effective across a broad spectrum of breast cancer subtypes by Friedland, Julie C., Smith, Donald L., Sang, Jim, Acquaviva, Jaime, He, Suqin, Zhang, Chaohua, Proia, David A.

    Published in Investigational new drugs (01-02-2014)
    “…Summary Heat shock protein 90 (Hsp90) is a molecular chaperone essential for the stability and function of multiple cellular client proteins, a number of which…”
    Get full text
    Journal Article
  9. 9

    alpha 6 beta 4 integrin activates Rac-dependent p21-activated kinase 1 to drive NF- Kappa B-dependent resistance to apoptosis in 3D mammary acini by Friedland, Julie C, Lakins, Johnathon N, Kazanietz, Marcelo G, Chernoff, Jonathan, Boettiger, David, Weaver, Valerie M

    Published in Journal of cell science (15-10-2007)
    “…Malignant transformation and multidrug resistance are linked to resistance to apoptosis, yet the molecular mechanisms that mediate tumor survival remain poorly…”
    Get full text
    Journal Article
  10. 10

    α6β4 integrin activates Rac-dependent p21-activated kinase 1 to drive NF-κB-dependent resistance to apoptosis in 3D mammary acini by Friedland, Julie C, Lakins, Johnathon N, Kazanietz, Marcelo G, Chernoff, Jonathan, Boettiger, David, Weaver, Valerie M

    Published in Journal of cell science (15-10-2007)
    “…Malignant transformation and multidrug resistance are linked to resistance to apoptosis, yet the molecular mechanisms that mediate tumor survival remain poorly…”
    Get full text
    Journal Article
  11. 11

    Traumatic brain injury elevates glycogen and induces tolerance to ischemia in rat brain by Otori, Tatsuo, Friedland, Julie C, Sinson, Grant, McIntosh, Tracy K, Raghupathi, Ramesh, Welsh, Frank A

    Published in Journal of neurotrauma (01-06-2004)
    “…Previous studies have demonstrated that traumatic brain injury (TBI) increases the vulnerability of the brain to an acute episode of hypoxia-ischemia. The…”
    Get more information
    Journal Article
  12. 12
  13. 13

    Case report: response to the ERK1/2 inhibitor ulixertinib in BRAF D594G cutaneous melanoma by Wolfe, Zachary, Friedland, Julie C., Ginn, Sarah, Blackham, Aaron, Demberger, Lauren, Horton, Morgan, McIntosh, Alyson, Sheikh, Hina, Box, Jessica, Knoerzer, Deborah, Federowicz, Bryan, Stuhlmiller, Timothy J., Shapiro, Mark, Nair, Suresh

    Published in Melanoma research (12-05-2022)
    “…Melanoma is characterized by oncogenic mutations in pathways regulating cell growth, proliferation, and metabolism. Greater than 80% of primary melanoma cases…”
    Get full text
    Journal Article
  14. 14

    Abstract 1038: Inhibition of mTOR enhances the activity of HSP90 inhibitors in part through cessation of heat shock protein synthesis by He, Suqin, Acquaviva, Jaime, Friedland, Julie C., Sang, Jim, Smith, Donald L., Sequeira, Manuel, Zhang, Chaohua, Proia, David A.

    Published in Cancer research (Chicago, Ill.) (15-04-2013)
    “…Background: Heat shock protein 90 (HSP90) is a molecular chaperone required for the stability of hundreds of client proteins, many of which promote tumor…”
    Get full text
    Journal Article
  15. 15

    Mechanically Activated Integrin Switch Controls α 5 β 1 Function by Friedland, Julie C., Lee, Mark H., Boettiger, David

    “…The cytoskeleton, integrin-mediated adhesion, and substrate stiffness control a common set of cell functions required for development and homeostasis that are…”
    Get full text
    Journal Article
  16. 16

    Mechanically Activated Integrin Switch Controls [alpha]5[beta]1 Function by Friedland, Julie C, Lee, Mark H, Boettiger, David

    “…The cytoskeleton, integrin-mediated adhesion, and substrate stiffness control a common set of cell functions required for development and homeostasis that are…”
    Get full text
    Journal Article
  17. 17

    Preclinical activity of the Hsp90 inhibitor, ganetespib, in ALK- and ROS1-driven cancers by Proia, David A, Acquaviva, Jaime, Jiang, Qin, Xue, Liquan, Smith, Donald, Friedland, Julie C, He, Suqin, Sang, Jim, Morris, Stephan, Wada, Yumiko

    Published in Journal of clinical oncology (20-05-2012)
    “…Abstract only 3090 Background: Ganetespib is a potent inhibitor of heat shock protein 90 (Hsp90) currently being studied in a broad range of clinical trials…”
    Get full text
    Journal Article
  18. 18

    alpha6beta4 integrin activates Rac-dependent p21-activated kinase 1 to drive NF-kappaB-dependent resistance to apoptosis in 3D mammary acini by Friedland, Julie C, Lakins, Johnathon N, Kazanietz, Marcelo G, Chernoff, Jonathan, Boettiger, David, Weaver, Valerie M

    Published in Journal of cell science (15-10-2007)
    “…Malignant transformation and multidrug resistance are linked to resistance to apoptosis, yet the molecular mechanisms that mediate tumor survival remain poorly…”
    Get full text
    Journal Article
  19. 19

    Mechanically activated integrin switch controls alpha5beta1 function by Friedland, Julie C, Lee, Mark H, Boettiger, David

    “…The cytoskeleton, integrin-mediated adhesion, and substrate stiffness control a common set of cell functions required for development and homeostasis that are…”
    Get full text
    Journal Article
  20. 20

    Spatial-mechanical regulation of the small GTPase Rac in mammary epithelial cell survival and apoptosis resistance by Friedland, Julie C

    Published 01-01-2006
    “…Cells in vivo exist in a three-dimensional (3D) compliant microenvironment, and stromal-epithelial interactions regulate mammary morphogenesis and modulate…”
    Get full text
    Dissertation